10x Genomics' Xenium Platform to Support Breast Cancer Biomarker StudyZacks Investment Research • Thursday
Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics' Xenium PlatformPRNewsWire • Tuesday
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/06/26
10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium AnalysisPRNewsWire • 11/02/26
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?The Motley Fool • 10/12/26
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker ResearchZacks Investment Research • 10/08/26
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood CancersPRNewsWire • 10/07/26
10x Genomics Begins Atera Shipments as Spatial Biology Demand RisesZacks Investment Research • 09/30/26
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental ConclusionsPRNewsWire • 09/29/26
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' HandsPRNewsWire • 09/29/26
Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical ResearchPRNewsWire • 09/10/26
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?Zacks Investment Research • 09/03/26
TXG Stock Down Despite Patent Verdict Win Against Parse BiosciencesZacks Investment Research • 08/31/26